Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-424.25%EBITDA Margin
VS
Market
Sector
Industry
History
$ 0.15Close
$ 0.15 - $ 1.11 52-Week Range
Ticker Information
Ticker
CARMCompany Name
CARISMA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCARISMA THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CARM - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -45.68M | -424.25% | $ 10.77M |
| 3/31/2025 | $ -44.47M | -222.76% | $ 19.96M |
| 12/31/2024 | $ -52.16M | -265.69% | $ 19.63M |
| 9/30/2024 | $ -55.99M | -276.26% | $ 20.27M |
| 6/30/2024 | $ -65.3M | -315.3% | $ 20.71M |
| 3/31/2024 | $ -75.98M | -504.11% | $ 15.07M |
| 12/31/2023 | $ -80.55M | -539.92% | $ 14.92M |
| 9/30/2023 | $ -67.76M | -637.42% | $ 10.63M |
| 6/30/2023 | $ -27.05M | -57.8% | $ 46.8M |
| 3/31/2023 | $ -43.99M | -101.72% | $ 43.24M |
Key Performance Insights, Last 5 Years
- CARISMA THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at -352.99%.
- Over the past 5 years, CARISMA THERAPEUTICS INC's average EBITDA % has been -275.45%.
- The median EBITDA % for CARISMA THERAPEUTICS INC during this period was -270.98%
- CARISMA THERAPEUTICS INC reached its highest EBITDA % over the past 5 years at 206.09%.
- The lowest EBITDA % recorded by CARISMA THERAPEUTICS INC in the same timeframe -756.59%
CARISMA THERAPEUTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for CARISMA THERAPEUTICS INC is calculated as follows: EBITDA [ $ -39.66M ] / Revenues [ $ 11.24M ]
(=) EBITDA % [ -352.99% ] CARM - EBITDA Margin, Last 5 years
-756.59%
Minimum
Mar 31, 2021
206.09%
Maximum
Mar 31, 2022
-275.45%
Average
-270.98%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.15% with a standard deviation of 26.84%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.98% |
| max | 97.73% |
| average | 16.15% |
| median | 14.67% |
| std | 26.84% |